ZA908935B - Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones - Google Patents

Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones

Info

Publication number
ZA908935B
ZA908935B ZA908935A ZA908935A ZA908935B ZA 908935 B ZA908935 B ZA 908935B ZA 908935 A ZA908935 A ZA 908935A ZA 908935 A ZA908935 A ZA 908935A ZA 908935 B ZA908935 B ZA 908935B
Authority
ZA
South Africa
Prior art keywords
pyridinyloxazole
glycoprotein
ones
prevention
enveloped virus
Prior art date
Application number
ZA908935A
Other languages
English (en)
Inventor
Sai Prasad Sunkara
Prasad Sunkara Sai
Winton Dennis Jones
Dennis Jones Winton
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA908935B publication Critical patent/ZA908935B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA908935A 1989-11-13 1990-11-07 Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones ZA908935B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43626489A 1989-11-13 1989-11-13

Publications (1)

Publication Number Publication Date
ZA908935B true ZA908935B (en) 1991-08-28

Family

ID=23731771

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908935A ZA908935B (en) 1989-11-13 1990-11-07 Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones

Country Status (7)

Country Link
EP (1) EP0428103A3 (de)
JP (1) JP2927932B2 (de)
KR (1) KR0162638B1 (de)
AU (1) AU630248B2 (de)
IE (1) IE904075A1 (de)
PH (1) PH26858A (de)
ZA (1) ZA908935B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514781A (en) * 1994-04-11 1996-05-07 Bayer Corporation Use of azoles as virucidal agents in solutions of biologically active proteins
US6291446B1 (en) 1998-03-05 2001-09-18 Eli Lilly And Company Therapeutic treatment for cytomegalovirus infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones

Also Published As

Publication number Publication date
IE904075A1 (en) 1991-05-22
EP0428103A3 (en) 1991-12-11
PH26858A (en) 1992-11-16
JPH03170426A (ja) 1991-07-24
KR910009263A (ko) 1991-06-28
JP2927932B2 (ja) 1999-07-28
KR0162638B1 (ko) 1998-12-01
AU630248B2 (en) 1992-10-22
AU6592590A (en) 1991-05-16
EP0428103A2 (de) 1991-05-22

Similar Documents

Publication Publication Date Title
HK38293A (en) Hepatitis c virus
GB8801338D0 (en) Preservation of viruses
PL321966A1 (en) Vaccine against viral hepatitis of b type
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
GB2212511B (en) Hepatitis c virus
PL324906A1 (en) Vaccines against viral hepatitis of c type
HUT58371A (en) Recombinant virus of marek-disease
EP0431064A4 (en) Recombinant vaccinia virus for prevention of disease caused by flavivirus
ZA924150B (en) Vaccine for human immunodeficiency virus
PL307402A1 (en) Vaccine containing a hepatitis a virus
EP0210931A3 (en) Vaccine against varicella-zoster virus
HU9300010D0 (en) Glycoprotein vaccine named ehv-4
GB9208545D0 (en) Virus resistant plants
ZA908935B (en) Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones
ZA908189B (en) Infectious bronchitis virus vaccine
EP0468702A3 (en) Novel process for purification of hepatitis-a virus capsids
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
GB8914680D0 (en) Prevention of aid virus
IE883428L (en) Dsrn based prevention of viral escape
GB2236251B (en) Anti-aids virus agent
EP0436200A3 (en) Ceramic package
GB8712042D0 (en) Virus & vaccine
GB8608991D0 (en) Virus vaccine
GR3003377T3 (en) Virus vaccine
GB8406901D0 (en) Virus vaccine